The dawn of 2026 has introduced a new era of "precision cardiology" for patients with inherited metabolic syndromes. With cardiovascular complications being the leading cause of mortality in these populations, researchers have focused on identifying blood-based markers that can predict the onset of fibrosis before it is visible on a standard echocardiogram. These high-sensitivity assays are now...
Portuguese 
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt